Today: 29 April 2026
Browse Category

TSX:6501 25 August 2025 - 5 January 2026

Tokyo Stock Exchange Surges to Record Highs on AI Boom – Inside the Nov 3, 2025 Rally

Tokyo Stock Exchange Surges to Record Highs on AI Boom – Inside the Nov 3, 2025 Rally

Tokyo’s Nikkei 225 closed at a record 52,411.34, up 2.1%, marking its biggest monthly gain since 1994. The TOPIX and Mothers Index also hit record highs, led by surging tech shares as Advantest jumped 22% and Konami 16.1%. Toyota slipped 1.5% ahead of earnings, while a weaker yen boosted exporters. Investors cited optimism over AI, fiscal stimulus, and global market gains.
3 November 2025
········
Google’s Shocking AI Contractor Purge: The Real Reason 200 ‘Super Raters’ Were Axed

Google’s Shocking AI Contractor Purge: The Real Reason 200 ‘Super Raters’ Were Axed

Google cut more than 200 AI contractors in August 2025, citing a project ramp-down. Workers allege the real reason was retaliation for unionizing efforts and complaints over pay and job security. The contractors, employed by GlobalLogic, helped train Google’s AI products. Google says GlobalLogic, not Alphabet, is responsible for employment conditions.
17 September 2025
··
Quantum Leaps and Big Bets: Global Quantum Breakthroughs & Deals (Aug 24–25, 2025)

Quantum Leaps and Big Bets: Global Quantum Breakthroughs & Deals (Aug 24–25, 2025)

USC researchers showed that adding a 'neglecton' quasiparticle to Ising anyons enables universal topological quantum computing, published in Nature Communications. IBM's 5-qubit chip with T-REx achieved chemical calculations ten times more accurate than a 156-qubit device. Strangeworks announced its acquisition of Quantagonia, while QuamCore raised $26 million to pursue a million-qubit superconducting quantum computer.
25 August 2025
·····

Stock Market Today

  • Sensex Rallies 609 Points as Nifty Nears 24,200 on Strong Earnings and Geopolitical Hope
    April 29, 2026, 9:39 AM EDT. Indian benchmark indices rebounded Wednesday with the BSE Sensex rising 609 points (0.79%) to 77,496.36 and the NSE Nifty climbing 182 points (0.76%) to 24,177.65. Gains were broad-based, led by FMCG, auto, and telecom stocks. Maruti Suzuki surged nearly 3% following a record annual net profit, lifted by highest-ever sales and GST rate cuts. Positive earnings reports and easing geopolitical tensions fueled investor sentiment despite elevated crude oil prices which rose 2.85% to $114.4 a barrel. Asian markets also closed higher, reflecting a global mood shift. However, European and U.S. markets remained subdued. Analysts noted improved corporate performance and hopes of reduced global conflicts helped offset macroeconomic concerns and contributed to today's rebound.

Latest article

Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

29 April 2026
Cambridge, Massachusetts, April 29, 2026, 09:04 EDT Biogen Inc. cut its full-year profit outlook on Wednesday, taking some shine off a first-quarter earnings beat driven by stronger sales of its Alzheimer’s drug Leqembi and newer rare-disease medicines. The Cambridge, Massachusetts-based drugmaker now expects 2026 adjusted earnings of $14.25 to $15.25 a share, down $1 at both ends of its prior range. Biogen said the cut reflects acquired in-process research and development charges, meaning costs tied to buying or licensing drug programs that are still being developed and have not yet become commercial products. (marketscreener.com) The revision matters because Biogen is
Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
Go toTop